Related Experiment Videos
[Differential Diagnosis Macro CK Type 1 in Thoracic Pain Syndrome and Increased CK-MB]
Eva-Susanne Strobel1, Emanuel Fritschka, Erika Schimke
1Paracelsus-Klinik, Bad Elster.
Insights
Macro creatine kinase (CK) can elevate CK-MB levels, mimicking cardiac events in patients without heart conditions. This case highlights macro CK as a crucial differential diagnosis for elevated CK, especially in cardially healthy individuals.
Area of Science:
- Biochemistry
- Clinical Diagnostics
- Cardiology
Background:
- Macro creatine kinase (CK), a known cause of elevated CK levels since 1979, can complicate myocardial infarction diagnosis.
- Elevated CK values, particularly CK-MB, can arise before troponin levels increase, causing diagnostic confusion.
Observation:
- A 73-year-old prostate cancer patient, treated with hormone therapy and radiation, presented with exertional dyspnea and chest tightness.
- Serum CK was elevated at 232 U/l with CK-MB at 62 U/l, while troponin T and other cardiac markers were negative.
- Cardiac events were excluded through clinical evaluation and serial ECGs.
Findings:
- Isoenzyme electrophoresis identified the cause as a macro CK-BB-IgG complex type 1 (macro CK-1).
- This finding underscores macro CK as a potential cause of elevated CK-MB in patients without cardiac disease.
Implications:
- High CK-MB values in cardiac-healthy patients warrant consideration of macro CK as a differential diagnosis.
- Macro CK, present in about 0.5% of cases, should be routinely considered to avoid misdiagnosis.
Background:
Macro CK (creatine kinase) as a reason for high CK values has been known since 1979. Even in the era of troponin determination for the diagnosis of myocardial infarction, an elevated CK value can still cause confusion, especially as CK-MB rises earlier than troponin. The case report should remind us of this often forgotten differential diagnosis of elevated CK.
Case Report:
A 73-year-old patient was treated with leuprorelin hormone therapy for prostate cancer (stage pT1c G2). In addition, he received percutaneous radiation therapy of the prostate and high-dose-rate brachytherapy twice with 10 Gy each. Close to 1 year later, he complained for the first time of dyspnea on exertion and thoracic tightness. Serum CK was 232 U/l, and CK-MB 62 U/l, which was confirmed by several controls. Troponin T test was negative, and GOT, GPT, LDH, and PSA were all within the normal range. Acute myocardial infarction was ruled out on clinical grounds and by six sequential ECGs. Subsequently, the patient remained without further cardiac complaints and in good condition. Isoenzyme electrophoresis finally solved the problem and revealed CK-BB-IgG complex type 1 (macro CK-1).
Conclusion:
High CK-MB values in cardially healthy patients should remind us of the possibility of macro CK which is seen in approximately 0.5% of cases and should be included in the differential diagnosis.
Related Concept Videos
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Chronic Kidney Disease II: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy